{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:41:15Z","timestamp":1791996075964,"version":"4.4.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of KwaZulu-Natal College of Health Sciences Doctoral Research Scholarship grant","award":["636765"],"award-info":[{"award-number":["636765"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Cervical cancer imposes considerable economic burden on societies and individuals. There is lack of evidence regarding this from the developing world and particularly from sub-Saharan Africa. Therefore, the study aimed to estimate the societal costs of cervical cancer in Eswatini.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Materials and methods<\/jats:title>\n<jats:p>The cost of illness study (CoI) was applied using national specific clinical and registry data from hospitals, registries and reports to determine the prevalence of cervical intraepithelial neoplasia (CIN) and cervical cancer in Eswatini in 2018. Cost data included direct medical costs (health care utilization in inpatient and outpatient care), direct non-medical costs (patient costs for traveling) and indirect costs based on productivity loss due to morbidity (patient time during diagnosis and treatment) and premature mortality.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The estimated total annual cost for cervical cancer was $19 million (ranging between $14 million and $24 million estimated with lower and upper bounds). Direct cost represented the majority of the costs at 72% ($13.7 million) out of which total pre-cancerous treatment costs accounted for 0.7% ($94,161). The management of invasive cervical cancer was the main cost driver with costs attributable to treatment for FIGO III and FIGO IV representing $1.7 million and $8.7 million respectively. Indirect costs contributed 27% ($5.3 million) out of which productivity loss due to premature mortality represented the majority at 67% ($3.5 million).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The economic burden of cervical cancer in Eswatini is substantial. National public health prevention strategies with prophylactic HPV vaccine and screening for cervical lesions should therefore be prioritized to limit the extensive costs associated with cervical cancer.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0250113","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T21:53:02Z","timestamp":1618523582000},"page":"e0250113","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["The economic burden of cervical cancer in Eswatini: Societal perspective"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2960-1558","authenticated-orcid":true,"given":"Cebisile","family":"Ngcamphalala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellinor","family":"\u00d6stensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0993-8308","authenticated-orcid":true,"given":"Themba G.","family":"Ginindza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"pone.0250113.ref001","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bpobgyn.2017.08.006","article-title":"Epidemiology and burden of HPV-related disease","volume":"47","author":"B Serrano","year":"2018","journal-title":"Best Practice & Research Clinical Obstetrics & Gynaecology"},{"issue":"9","key":"pone.0250113.ref002","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","article-title":"Global burden of cancers attributable to infections in 2012: a synthetic analysis","volume":"4","author":"M Plummer","year":"2016","journal-title":"The Lancet Global Health"},{"issue":"1","key":"pone.0250113.ref003","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"JM Walboomers","year":"1999","journal-title":"The Journal of pathology"},{"issue":"14","key":"pone.0250113.ref004","doi-asserted-by":"crossref","first-page":"e9545","DOI":"10.1097\/MD.0000000000009545","article-title":"Detection and genotyping of human papillomavirus (HPV) in HIV-infected women and its relationship with HPV\/HIV co-infection","volume":"97","author":"RM Badial","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"pone.0250113.ref005","doi-asserted-by":"crossref","first-page":"A68","DOI":"10.1016\/S1098-3015(10)70225-4","article-title":"PCN47 IMPACT OF HIV INFECTION ON INVASIVE CERVICAL CANCER INCIDENCE AND TREATMENT COSTS IN SOUTH AFRICAN WOMEN","volume":"11","author":"A Vijayaraghavan","year":"2008","journal-title":"Value in Health"},{"key":"pone.0250113.ref006","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"F Bray","year":"2018","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"10071","key":"pone.0250113.ref007","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0140-6736(16)31392-7","article-title":"The global burden of women\u2019s cancers: a grand challenge in global health","volume":"389","author":"O Ginsburg","year":"2017","journal-title":"The Lancet"},{"issue":"12","key":"pone.0250113.ref008","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S1470-2045(13)70442-X","article-title":"Economic burden of cancer across the European Union: a population-based cost analysis","volume":"14","author":"R Luengo-Fernandez","year":"2013","journal-title":"The Lancet Oncology"},{"key":"pone.0250113.ref009","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.canep.2017.12.013","article-title":"Productivity losses due to premature mortality from cancer in Brazil, Russia, India, China, and South Africa (BRICS): A population-based comparison","volume":"53","author":"A Pearce","year":"2018","journal-title":"Cancer epidemiology"},{"issue":"1","key":"pone.0250113.ref010","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.9778\/cmajo.20170144","article-title":"The economic burden of cancer care in Canada: a population-based cost study","volume":"6","author":"C de Oliveira","year":"2018","journal-title":"CMAJ Open"},{"issue":"9","key":"pone.0250113.ref011","doi-asserted-by":"crossref","first-page":"e0139062","DOI":"10.1371\/journal.pone.0139062","article-title":"Cost of preventing, managing, and treating human papillomavirus (HPV)-related diseases in Sweden before the introduction of quadrivalent HPV vaccination","volume":"10","author":"E \u00d6stensson","year":"2015","journal-title":"PloS one"},{"issue":"7","key":"pone.0250113.ref012","doi-asserted-by":"crossref","first-page":"e0200554","DOI":"10.1371\/journal.pone.0200554","article-title":"Correction: The economic burden of human papillomavirus-related precancers and cancers in Sweden","volume":"13","author":"E \u00d6stensson","year":"2018","journal-title":"PloS one"},{"issue":"3","key":"pone.0250113.ref013","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2307\/3349801","article-title":"Cost-of-Illness Methodology: A Guide to Current Practices and Procedures","volume":"60","author":"TA Hodgson","year":"1982","journal-title":"The Milbank Memorial Fund Quarterly Health and Society"},{"issue":"5","key":"pone.0250113.ref014","doi-asserted-by":"crossref","first-page":"e0177762","DOI":"10.1371\/journal.pone.0177762","article-title":"Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland","volume":"12","author":"TG Ginindza","year":"2017","journal-title":"PloS one"},{"key":"pone.0250113.ref015","volume-title":"Methods for the economic evaluation of health care programmes","author":"MF Drummond","year":"2015"},{"issue":"6","key":"pone.0250113.ref016","doi-asserted-by":"crossref","first-page":"e0179520","DOI":"10.1371\/journal.pone.0179520","article-title":"The economic burden of human papillomavirus-related precancers and cancers in Sweden","volume":"12","author":"E \u00d6stensson","year":"2017","journal-title":"PLoS One"},{"key":"pone.0250113.ref017","unstructured":"Mogyorosy Z, Smith P: The main methodological issues in costing health care services: a literature review. In.; 2005."},{"key":"pone.0250113.ref018","unstructured":"Ministry-of-Health.: Phalala Fund Annual Report. In. Eswatini; 2018."},{"key":"pone.0250113.ref019","unstructured":"Ministry-of-Health: Sexual Reproductive Health Annual Program Report. In. Eswatini: Monitoring and Evaluation Unit; 2018."},{"key":"pone.0250113.ref020","unstructured":"Ministry-of-Health: Eswatini Standardized Cancer Care and Guidelines. In. Eswatini: National Cancer Registry; 2020."},{"issue":"1","key":"pone.0250113.ref021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00019053-199813010-00001","article-title":"How to calculate indirect costs in economic evaluations","volume":"13","author":"B Liljas","year":"1998","journal-title":"Pharmacoeconomics"},{"issue":"7","key":"pone.0250113.ref022","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/aogs.12143","article-title":"Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program","volume":"92","author":"E \u00d6stensson","year":"2013","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"12","key":"pone.0250113.ref023","first-page":"DS197","article-title":"Panel on cost-effectiveness in health and medicine","volume":"34","author":"M Gold","year":"1996","journal-title":"Medical care"},{"issue":"4","key":"pone.0250113.ref024","doi-asserted-by":"crossref","first-page":"E136","DOI":"10.1002\/ijc.29105","article-title":"Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe","volume":"136","author":"P Hanly","year":"2015","journal-title":"Int J Cancer"},{"issue":"12","key":"pone.0250113.ref025","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s40273-018-0697-3","article-title":"Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models","volume":"36","author":"AJ Hatswell","year":"2018","journal-title":"PharmacoEconomics"},{"key":"pone.0250113.ref026","unstructured":"Ministry-of-Health: Eswatini National Cancer Registry In. Edited by Health Mo. Eswatini; 2018."},{"issue":"7","key":"pone.0250113.ref027","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1634\/theoncologist.2017-0481","article-title":"Costs of cancer care across the disease continuum","volume":"23","author":"DR Kaye","year":"2018","journal-title":"The oncologist"},{"issue":"5","key":"pone.0250113.ref028","first-page":"615.e611","article-title":"Phase-specific healthcare costs of cervical cancer: estimates from a population-based study","volume":"214","author":"N Liu","year":"2016","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"12","key":"pone.0250113.ref029","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/S0959-8049(98)00232-9","article-title":"Stage-specific treatment costs for cervical cancer in the United Kingdom","volume":"34","author":"JL Wolstenholme","year":"1998","journal-title":"European Journal of Cancer"},{"issue":"5","key":"pone.0250113.ref030","doi-asserted-by":"crossref","first-page":"e0232129","DOI":"10.1371\/journal.pone.0232129","article-title":"The economic burden of cervical cancer from diagnosis to one year after final discharge in Henan Province, China: A retrospective case series study","volume":"15","author":"Q Wu","year":"2020","journal-title":"PloS one"},{"issue":"6C","key":"pone.0250113.ref031","first-page":"4473","article-title":"Human papillomavirus (HPV), DNA aberrations and cell cycle progression in anal squamous cell carcinoma patients","volume":"27","author":"N Laytragoon-Lewin","year":"2007","journal-title":"Anticancer research"},{"issue":"21","key":"pone.0250113.ref032","first-page":"4181","volume":"124","author":"M Pisu","year":"2018","journal-title":"Costs of cancer along the care continuum: What we can expect based on recent literature"},{"key":"pone.0250113.ref033","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1016\/j.jval.2018.09.1340","article-title":"PIN21-ECONOMIC BURDEN OF CERVICAL SCREENING AND TREATMENT OF HPV-RELATED CERVICAL LESIONS AND CANCERS IN EUROPE","volume":"21","author":"H Patel","year":"2018","journal-title":"Value in Health"},{"issue":"6 Suppl 1","key":"pone.0250113.ref034","first-page":"S177","article-title":"Assessing the short-term and long-term burden of illness in cervical cancer","volume":"14","author":"RJ Lipsy","year":"2008","journal-title":"The American journal of managed care"},{"issue":"5","key":"pone.0250113.ref035","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.whi.2006.06.005","article-title":"Annual productivity costs due to cervical cancer mortality in the United States","volume":"16","author":"RP Insinga","year":"2006","journal-title":"Women\u2019s Health Issues"},{"issue":"2","key":"pone.0250113.ref036","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S2352-3018(16)30190-4","article-title":"Swaziland HIV Incidence Measurement Survey (SHIMS): a prospective national cohort study","volume":"4","author":"J Justman","year":"2017","journal-title":"The lancet HIV"},{"issue":"3.5","key":"pone.0250113.ref037","first-page":"HSR19","volume":"17","author":"C Nwankwo","year":"2019","journal-title":"HSR19-102: Direct and Indirect Economic Burden of Cervical Cancer (CxCa) in the United States in 2015: A Mixed-Methods Analysis"},{"issue":"6","key":"pone.0250113.ref038","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1183\/09031936.00193413","article-title":"Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review","volume":"43","author":"T Tanimura","year":"2014","journal-title":"European Respiratory Journal"},{"issue":"4","key":"pone.0250113.ref039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2471-268x.1000142","article-title":"Cost of illness of breast cancer patients on chemotherapy in Addis Ababa Public Hospitals, the case of Tikur Anbessa specialized teaching hospital-cross-sectional types of study","volume":"3","author":"G Mamo","year":"2017","journal-title":"Health Economics & Outcome Research: Open Access"},{"issue":"9","key":"pone.0250113.ref040","first-page":"1225","article-title":"The economic burden of breast cancer in Iran","volume":"44","author":"R Daroudi","year":"2015","journal-title":"Iranian journal of public health"},{"issue":"8","key":"pone.0250113.ref041","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/modpathol.2008.91","article-title":"HPV DNA detection and genotyping in 21 cases of primary invasive squamous cell carcinoma of the vagina","volume":"21","author":"M Ferreira","year":"2008","journal-title":"Modern Pathology"},{"issue":"2","key":"pone.0250113.ref042","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/sti.2003.008318","article-title":"The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic","volume":"81","author":"P Fox","year":"2005","journal-title":"Sexually transmitted infections"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0250113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T21:53:46Z","timestamp":1618523626000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0250113"}},"subtitle":[],"editor":[{"given":"Shinya","family":"Tsuzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0250113","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]}}}